Prasad overruled FDA scientists on Moderna application, STAT says

Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research, overruled the agency’s reviewers in refusing to accept Moderna’s (MRNA) application for a new influenza vaccine, Lizzy Lawrence of STAT reports, citing three officials familiar with the matter. A team of career scientists was ready to review Moderna’s application, sources told the website. Shares of Moderna are down 10% to $37.93 in morning trading.